Moderna COVID-19 boosters: FDA panel endorses lower-dose shots for seniors, high risk

Name: Moderna COVID-19 boosters: FDA panel endorses lower-dose shots for seniors, high risk
Uploaded: 2021-10-14T21:41:47Z
Duration: 24 s
Description: A panel of independent advisers to the U.S. Food and Drug Administration unanimously voted to endorse lower-dose booster shots of Moderna’s COVID-19 vaccine for seniors and other high-risk groups.

A panel of independent advisers to the U.S. Food and Drug Administration unanimously voted to endorse lower-dose booster shots of Moderna’s COVID-19 vaccine for seniors and other high-risk groups.

Posted October 14, 2021 5:41pm EDT